NCT05649774

Brief Summary

Lower back pain has been one of the most frequently occurring musculoskeletal disorder among the females. This act as a global burden and is highly prevalent in our society. This pain can result in life long disability, loss of function and mobility among individuals. The female of the society suffers from lower back pain the most because of the under lying causes, prolong standing and stooping as well as because of hormonal changes in their bodies

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 19, 2022

Completed
25 days until next milestone

First Posted

Study publicly available on registry

December 14, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

December 14, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2023

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 25, 2023

Completed
Last Updated

January 31, 2023

Status Verified

January 1, 2023

Enrollment Period

1 month

First QC Date

November 19, 2022

Last Update Submit

January 29, 2023

Conditions

Keywords

Lower back painNon specific lower back pain

Outcome Measures

Primary Outcomes (2)

  • Lower Back Pain

    Numeric Pain Rating Scale

    Change from baseline to week 3

  • Disability of lower back

    Oswestry Disability Index

    Change from baseline to week 3

Secondary Outcomes (4)

  • Range of Motion

    Change from baseline to week 3

  • Pain Pressure Threshold

    Change from baseline to week 3

  • Tissue Hardness

    Change from baseline to week 3

  • Quality of Life of patients with Lower back pain

    Change from baseline to week 3

Study Arms (4)

Myofascial Release (MFR)

ACTIVE COMPARATOR

The therapist will place its hands on the T12-L1 levels as well as on the sacrum. A cross handed hold will be performed along the fascia. Then for the gluteus Medius and maximus muscle, the therapist will stand facing the participant's leg and closed to the superior border of participant's pelvis. The therapist will place the palm of the hand on the anterior surface, allowing the fingers to rest on the outer fibers of the gluteal muscles stabilizing the pelvis of the participants. Allow the participant to flex its knee while applying adequate amount of stretch on the hip joint in an open pack position. Hold, wait for the release and stretch again. for tensor fascia Latae, The therapist will place several slightly adducted fingers of its one hand on the superior fibers proximal to the insertion on the anterior superior iliac crest and the thumb as well as the other fingers of the other hand on the distal muscle fibers. Hold, wait for the release and stretch again.

Procedure: Therapy

Kinesio Taping (KT)

ACTIVE COMPARATOR

Lumbar star correction technique was applied. 4 tape I strips will be cut. The paper from the center will be torn. The targeted area will be stretched as tolerated at the lumbar region. The therapist will apply 25% to 35% tension to the strip within the therapeutic zone over the target tissue. End the strip with no tension and activate the adhesive. For the second strip change the posture in order to change the stretch on the tissue, apply the second strip with 25% to 35% tension in the center of the tape and end with no tension. Activate the adhesive. Now flex the trunk and rotate on one side. Apply the third tape strip with 25% to 35% tension in the center of the tape. Apply the fourth tape strip with flexion and rotation on the opposite side again with 25% to 35% tension on the strip. The tape will be changed 3 times per week.

Procedure: Taping technique

Myofascial Release with Taping (MFKT)

EXPERIMENTAL

Same Protocol of MFR followed by KT

Procedure: Therapy with taping

Placebo Treatment

SHAM COMPARATOR

The control group received a sham myofascial release for 40 minutes per treatment session, three times a week for three weeks. The sham myofascial release was applied by gently placing the hands over the same areas treated in the MFR group,without sliding, just enough to maintain contact for the desired time.

Procedure: SHAM

Interventions

TherapyPROCEDURE

Only Myofascial Release will be provided

Also known as: Myofascial Release
Myofascial Release (MFR)

Only Kinesiotaping will be provided

Also known as: Taping
Kinesio Taping (KT)

Myofascial release will be provided followed by Kinesiotaping

Also known as: Therapy followed by taping
Myofascial Release with Taping (MFKT)
SHAMPROCEDURE

Placebo Treatment will be given

Placebo Treatment

Eligibility Criteria

Age28 Years - 38 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly females will be included in the study because lower back pain is highly prevalent among them.
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Females who were willing to participate.
  • Participants with nonspecific lower back pain will only be included and screened through the screening questionnaire.

You may not qualify if:

  • Post-menopausal women
  • Females with any diagnosed co-morbidity.
  • Back pain progressive to any neurological deficit
  • Sustained or increased back pain with loss of appetite and unexplained weight loss accompanied with fever, nausea and chills
  • With any known spinal or lower back pathology
  • Tumor of the spine
  • Any underlying diseases of spinal cord (i.e, ankylosing spondylosis, spondolisthesis)
  • With any steroid therapy for lower back pain in the past three months
  • Any inflammatory rheumatic disease
  • Sensitive skin or any skin allergy or dermatological condition
  • Any rehabilitative services taken for the lower back pain in the past two months
  • Rejection to manual conatct

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Al-Tibri Medical college and hospital

Karachi, Sindh, Pakistan

Location

MeSH Terms

Conditions

Low Back PainMusculoskeletal Diseases

Interventions

TherapeuticsMyofascial Release Therapysalicylhydroxamic acid

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

MassageTherapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Kiran Arshad, M.Phil

    University of Karachi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study was a parallel group, four arm superiority trial with 1:1 allocation ratio and balanced randomization
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 19, 2022

First Posted

December 14, 2022

Study Start

December 14, 2022

Primary Completion

January 20, 2023

Study Completion

January 25, 2023

Last Updated

January 31, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Data will be collected in the form of distribution of questionnaire to the participants. Confidentiality of the participants will be maintained. Consent will be taken form participants before collection of data.

Locations